Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin's lymphomas
| Autor: | Gene Wilson, Barry Brown, Peter McLaughlin, Marvin L. Meistrich, Rodger M. Pryzant |
|---|---|
| Rok vydání: | 1993 |
| Předmět: |
Adult
Male medicine.medical_specialty Vincristine Cancer Research Time Factors Cyclophosphamide Adolescent medicine.medical_treatment Urology Prednisone Antineoplastic Combined Chemotherapy Protocols medicine Humans Azoospermia Chemotherapy Radiotherapy Sperm Count business.industry Lymphoma Non-Hodgkin Combination chemotherapy Oligospermia Middle Aged medicine.disease Combined Modality Therapy Surgery Lymphoma Radiation therapy Oncology business medicine.drug |
| Zdroj: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 11(2) |
| ISSN: | 0732-183X |
| Popis: | PURPOSE Treatment of lymphomas with combination chemotherapy with or without radiation therapy (XRT) can result in long-term or permanent azoospermia. PATIENTS AND METHODS Semen analyses of lymphoma patients were performed before, during, and after treatment with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-Bleo) chemotherapy. Some of the patients also received other drugs or radiation therapy. RESULTS Although no patients were azoospermic before treatment, all were rendered azoospermic during treatment. Following the completion of treatment, the fraction of patients whose sperm counts recovered increased gradually over 5 years and plateaued by 7 years, with two thirds of the men achieving normospermic levels. Scattered gonadal radiation dose and cumulative cyclophosphamide dose were found to be independently significant determinants of recovery: the fraction of patients whose sperm counts recovered to 10 x 10(6)/mL were 83%, 47%, and 20% for those who received less than 9.5 g/m2 of cyclophosphamide, greater than 9.5 g/m2 of cyclophosphamide, and pelvic XRT, respectively. The inclusion of additional drugs and interferon alfa did not significantly affect the long-term recovery of spermatogenesis. CONCLUSION Pelvic XRT and cumulative cyclophosphamide dosages greater than 9.5 g/m2 are associated with a high risk of permanent sterility in lymphoma patients treated with the CHOP-Bleo regimen. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|